Zepbound® (tirzepatide) | 4 vials | 15 mg

Zepbound tirzepatide Weekly Injection 15 mg (4 Vials)

FDA-Approved Medication for Chronic Weight Management

Zepbound tirzepatide is an FDA-approved prescription injectable medication designed for long-term weight management in adults with obesity or overweight. It is indicated for patients who also have at least one weight-related health condition, such as type 2 diabetes, hypertension, or high cholesterol. Clinically proven and physician-prescribed, Zepbound® supports sustainable weight loss when combined with a reduced-calorie diet and increased physical activity.

Dual GIP & GLP-1 Receptor Agonist for Effective Results

Each vial of Zepbound® contains 15 mg of tirzepatide, a unique dual GIP and GLP-1 receptor agonist. This advanced mechanism of action works on key metabolic pathways to:

• Reduce appetite and food cravings
• Increase feelings of fullness after meals
• Support healthy blood sugar regulation
• Improve overall metabolic control

By targeting both receptors, Zepbound® offers enhanced weight-loss benefits compared to single-pathway therapies.

Once-Weekly Subcutaneous Injection

Zepbound® is administered once weekly via subcutaneous injection, making it a convenient option for long-term treatment adherence. The medication is supplied in pre-filled injection vials, ensuring accurate dosing and ease of use as prescribed by a healthcare provider.

Product Details & Specifications

• Medication Name: Zepbound® (tirzepatide)
• Dosage Strength: 15 mg per vial
• Dosage Form: Pre-filled injection vials
• Quantity: 4 vials
• Administration: Once-weekly subcutaneous injection
• Supply Duration: Typical 28-day treatment cycle

Designed for Long-Term Weight Management

Zepbound® is not a short-term solution but a medically supervised treatment intended for chronic weight management. When used consistently alongside lifestyle changes, it helps patients achieve and maintain meaningful weight loss while supporting overall metabolic health.